Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Emergent Biosolutions (EBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,224,078
  • Shares Outstanding, K 51,400
  • Annual Sales, $ 782,400 K
  • Annual Income, $ 62,700 K
  • 60-Month Beta 1.31
  • Price/Sales 2.85
  • Price/Cash Flow 12.16
  • Price/Book 2.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.16
  • Number of Estimates 3
  • High Estimate 0.31
  • Low Estimate 0.03
  • Prior Year 1.07
  • Growth Rate Est. (year over year) -85.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.29 +2.32%
on 05/21/19
54.51 -20.62%
on 04/25/19
-10.31 (-19.24%)
since 04/24/19
3-Month
42.29 +2.32%
on 05/21/19
64.12 -32.52%
on 02/25/19
-20.06 (-31.68%)
since 02/22/19
52-Week
42.29 +2.32%
on 05/21/19
73.89 -41.44%
on 12/03/18
-7.34 (-14.50%)
since 05/24/18

Most Recent Stories

More News
Emergent BioSolutions is Now Oversold (EBS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

EBS : 43.27 (-0.32%)
Emergent BioSolutions Announces Granting of Marketing Authorization in Five EU Countries for Its Oral Typhoid Vaccine; Expands Availability Across Europe

GAITHERSBURG, Md., May 20, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has successfully obtained marketing authorization for its oral typhoid vaccine Vivotif(R)...

EBS : 43.27 (-0.32%)
Emergent BioSolutions to Participate in Series of Investor Conferences

Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company's senior management team will participate in the following investor conferences during the second quarter of 2019:

EBS : 43.27 (-0.32%)
Emergent BioSolutions Prepares for Initial Shipments of AV7909 Anthrax Vaccine Candidate into the Strategic National Stockpile

Emergent BioSolutions Inc. (NYSE:EBS) announced today that the Biomedical Advanced Research and Development Authority (BARDA) has informed the company that it will begin procuring AV7909 (anthrax vaccine...

EBS : 43.27 (-0.32%)
Look for Shares of Emergent Biosolu to Potentially Rebound after Yesterday's 1.41% Sell Off

Emergent Biosolu (NYSE:EBS) traded in a range yesterday that spanned from a low of $44.13 to a high of $44.76. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $44.81...

EBS : 43.27 (-0.32%)
Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 23, 2019 at 9:00 AM EDT; Webcast Will Be Available

Emergent BioSolutions Inc. (NYSE: EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 23, 2019 beginning at 9:00 AM EDT at the Gaithersburg Marriott Washingtonian Center,...

EBS : 43.27 (-0.32%)
Emergent (EBS) Earnings & Revenues Miss Estimates in Q1

Emergent (EBS) incurs loss in the first quarter and misses on revenues as well.

PDLI : 2.96 (-0.67%)
EBS : 43.27 (-0.32%)
GSK : 40.18 (+0.48%)
SNY : 42.28 (+0.40%)
SmarTrend Watching for Potential Rebound in Shares of Emergent Biosolu After 10.60% Loss

Emergent Biosolu (NYSE:EBS) traded in a range yesterday that spanned from a low of $47.74 to a high of $50.56. Yesterday, the shares fell 10.6%, which took the trading range below the 3-day low of $51.22...

EBS : 43.27 (-0.32%)
New Strong Sell Stocks for May 3rd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

FCAU : 12.85 (+0.94%)
TV : 9.38 (+2.51%)
EBS : 43.27 (-0.32%)
IFNNY : 18.2000 (-1.89%)
SUPV : 5.90 (+2.61%)
Emergent Biosolutions (EBS) Reports Q1 Loss, Misses Revenue Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -200.00% and -6.88%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

EBS : 43.27 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade EBS with:

Business Summary

Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining...

See More

Key Turning Points

2nd Resistance Point 44.82
1st Resistance Point 44.04
Last Price 43.27
1st Support Level 42.73
2nd Support Level 42.20

See More

52-Week High 73.89
Fibonacci 61.8% 61.82
Fibonacci 50% 58.09
Fibonacci 38.2% 54.36
Last Price 43.27
52-Week Low 42.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar